Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 1;36(9):131.
doi: 10.1007/s11274-020-02907-1.

Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review

Affiliations
Review

Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review

Songhita Mukhopadhyay et al. World J Microbiol Biotechnol. .

Abstract

Antimicrobial resistance (AMR) is one of the significant clinical challenges and also an emerging area of concern arising from nosocomial infections of ESKAPE pathogens, which has been on the rise in both the developed and developing countries alike. These pathogens/superbugs can undergo rapid mutagenesis, which helps them to generate resistance against antimicrobials in addition to the patient's non-adherence to the antibiotic regimen. Sticking to the idea of a 'one-size-fits-all' approach has led to the inappropriate administration of antibiotics resulting in augmentation of antimicrobial resistance. Antimicrobial peptides (AMPs) are the natural host defense peptides that have gained attention in the field of AMR, and recently, synthetic AMPs are well studied to overcome the drawbacks of natural counterparts. This review deals with the novel techniques utilizing the bacteriolytic activity of natural AMPs. The effective localization of these peptides onto the negatively charged bacterial surface by using nanocarriers and structurally nanoengineered antimicrobial peptide polymers (SNAPPs) owing to its smaller size and better antimicrobial activity is also described here.

Keywords: Antimicrobial peptides; Antimicrobial resistance; ESKAPE pathogens; Nanostructured antimicrobial peptides; Structurally nanoengineered antimicrobial peptide polymers (SNAPPs).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
General mechanism of action of antimicrobial peptides; a represents attraction step where electrostatic bonding arises between negatively charged peptidoglycan layer of the bacterial cell membrane and amphiphilic polypeptide structure; b represents attachment step where the AMPs binds to Lipopolysaccharide (LPS) layer of Gram-negative cell wall and a teichoic acid layer of Gram-positive cell wall; c Represents the final peptide insertion step where following attachment the peptide forms a pore and thus disrupts the bacterial cell membrane
Fig. 2
Fig. 2
a Barrel-stave model of pore formation by AMPs, the hydrophobic region marked by red color aligns itself to the lipophilic part of the phospholipid bilayer, and the hydrophilic part represented by small orange part aligns itself towards the hydrophilic region of the phospholipid bilayer. b Carpet model of AMPs induced cell killing. Electrostatic bonding between the negatively charged bacterial cell surface and polypeptides aligns parallel to the cell membrane. c Toroidal pore model. AMPs induce the bending of the lipid monolayer in such a way that the polar head groups are both associated with the inserted peptides as well as the lipophilic
Fig. 3
Fig. 3
Formulation strategies of Antimicrobial peptides (Martin-Serrano et al. 2019)

References

    1. Almaaytah A, Mohammed GK, Abualhaijaa A, Al-Balas Q. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Drug Des Devel Ther. 2017;11:3159–3170. doi: 10.2147/DDDT.S147450. - DOI - PMC - PubMed
    1. Alvarez-Suarez J, Gasparrini M, Forbes-Hernández T, et al. The composition and biological activity of honey: a focus on Manuka honey. Foods. 2014;3:420–432. doi: 10.3390/foods3030420. - DOI - PMC - PubMed
    1. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: Opportunities and challenges in nanomedicine. Expert Opin Drug Deliv. 2010;7:753–763. doi: 10.1517/17425241003777010. - DOI - PMC - PubMed
    1. Ashley EA, Recht J, Chua A, et al. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000. J Antimicrob Chemother. 2018;73:1737–1749. doi: 10.1093/jac/dky026. - DOI - PMC - PubMed
    1. Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658. doi: 10.2147/IDR.S173867. - DOI - PMC - PubMed

MeSH terms